DR. CHAMBERS & PARTNERS
BALLYSILLAN GROUP PRACTICE, BALLYSILLAN GROUP PRACTICE, 156-158 BALLYSILLAN ROAD, BELFAST
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 14 | 15 | 93.3% | |
| HF 4 | 2011 | 13 | 15 | 86.7% | |
| HF 4 | 2012 | 13 | 15 | 86.7% | |
| HF 4 | 2013 | 16 | 18 | 88.9% | |
| HF004 | 2014 | 0 | 0 | NA% | |
| HF004 | 2015 | None | None | NA% | |
| HF004 | 2016 | None | None | NA% | |
| HF004 | 2017 | None | None | NA% | |
| HF004 | 2018 | None | None | NA% | |
| HF004 | 2019 | 6 | 6 | 100.0% | |
| HF004 | 2020 | 9 | 9 | 100.0% | |
| HF004 | 2021 | 12 | 12 | 100.0% |
